Unknown

Dataset Information

A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation.


ABSTRACT: Aberrant splicing is frequently found in cancer, yet the biological consequences of such alterations are mostly undefined. Here we report that the Hippo-YAP signalling, a key pathway that regulates cell proliferation and organ size, is under control of a splicing switch. We show that TEAD4, the transcription factor that mediates Hippo-YAP signalling, undergoes alternative splicing facilitated by the tumour suppressor RBM4, producing a truncated isoform, TEAD4-S, which lacks an N-terminal DNA-binding domain, but maintains YAP interaction domain. TEAD4-S is located in both the nucleus and cytoplasm, acting as a dominant negative isoform to YAP activity. Consistently, TEAD4-S is reduced in cancer cells, and its re-expression suppresses cancer cell proliferation and migration, inhibiting tumou

SUBMITTER: Qi Y 

PROVIDER: S-EPMC4909989 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature